Complex Regional Pain Syndrome (CRPS) Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the market

September 20 21:48 2022
Complex Regional Pain Syndrome (CRPS) Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the market
Complex Regional Pain Syndrome (CRPS) Market
DelveInsight’s “Complex Regional Pain Syndrome (CRPS) -Market Insight Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Complex Regional Pain Syndrome (CRPS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

DelveInsight’s “Complex Regional Pain Syndrome (CRPS) Market Insight  Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Complex Regional Pain Syndrome (CRPS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some of the key facts of the Complex Regional Pain Syndrome Market Report

  1.  The market size of CRPS is anticipated to increase during the study period, 2019–2032.

CRPS market is expected to be mainly driven by the rise in awareness and understanding of the disease and also the expected entry of emerging therapies. Other than this, the CRPS market may also rise due to increased funding and R&D activities.

  1. In the 7MM, the total gender-specific diagnosed prevalent cases of CRPS were  52,033 for males and ~112,312 for females in the year 2021.
  1. According to DelveInsight’s analysts, in the year 2021, the type-specific diagnosed prevalent cases for CRPS I and CRPS II were ~143,175 and ~21,170 cases, respectively

Key Benefits of the Report:

1 The Complex Regional Pain Syndrome (CRPS) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

2 The Complex Regional Pain Syndrome (CRPS) Epidemiology Report and Model provide an overview of the global trends of Complex Regional Pain Syndrome (CRPS) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)

3 The report provides insight into the historical and forecasted patient pool of Complex Regional Pain Syndrome (CRPS) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan

4 The report helps recognize the growth opportunities in the 7MM for the patient population

5 The report assesses the disease risk and burden and highlights the unmet needs of Complex Regional Pain Syndrome (CRPS)

6 The report provides the segmentation of the Complex Regional Pain Syndrome (CRPS) epidemiology

Got queries? Click here to know more about the Complex Regional Pain Syndrome (CRPS) Market Landscape

Complex Regional Pain Syndrome Overview

Complex regional pain syndrome (CRPS) is a broad term describing excess and prolonged pain and inflammation that follows an injury to an arm or leg or any part of the body. CRPS is clinically characterized by sensory, autonomic, and motor disturbances; it can affect any part of the body but occurs most often in the extremities. The wrist is most frequently affected after distal radial fractures, Complex regional pain syndrome can develop after different types of injuries, such as sprains and strains, surgeries, fractures, contusions, nerve lesions, stroke, etc.CRPS has acute (recent, short-term) and chronic (lasting greater than six months) forms. Besides the increased perception of pain, other signs and symptoms that are seen with CRPS, particularly in its early stages are a warm, red, and swollen extremity on the affected side.

There are two types of CRPS, Type I occurs after an illness or injury that did not directly damage a nerve in the affected area, and Type II follows a distinct nerve injury. Although the triggers vary, both types of CRPS have the same symptoms and go through the same three stages of the disease. CRPS used to be known as reflex sympathetic dystrophy (RSD) (Type I) and causalgia (Type II). Type I comprises about 90 percent of all cases of CRPS.

Patients typically progress through three stages as CRPS develops. CRPS in children does not always follow the same stage patterns and may only slowly improve or, at times, even stagnate.

1. Complex Regional Pain Syndrome Epidemiological Insights According to DelveInsight’s analysts, in the year 2021, the total prevalent case of CRPS was ~318,339 cases in the 7MM, which are expected to grow during the study period, i.e., 2019–2032

2. In 2021, the United States accounted for ~225,962 prevalent cases of CRPS,which are expected to grow during the study period, i.e., 2019–2032.

3. Among the EU-5 countries, the highest number of cases of CRPS were in Germany, i.e., ~21,243 cases in the year 2021, which are estimated to rise by 2032. 

4. In the 7MM, the total diagnosed prevalent cases of CRPS were ~164,346 cases in 2021. In EU-5 countries the highest number of diagnosed cases of CRPS were in Germany, followed by France, the United Kingdom, Italy, and Spain

Complex Regional Pain Syndrome  Epidemiological Segmentation 

1 Complex Regional Pain Syndrome Total Prevalent Cases 

2 Complex Regional Pain Syndrome Total Diagnosed Prevalent cases

3 Complex Regional Pain Syndrome Age-specific Diagnosed Prevalent Cases

4 Complex Regional Pain Syndrome Type-specific Diagnosed Prevalent Cases 

Complex Regional Pain Syndrome Market 

CRPS Syndrome is biomedically multifaceted, comprising both central and peripheral pathophysiology along with psychosocial components that need additional pivotal diagnostic features which can be a very challenging condition to treat successfully. To further add to the clinical challenges of managing CRPS, the epidemiology and natural history of CRPS are only superficially known. 

Learn more by requesting for sample @ Complex regional pain Market Landscape

Complex Regional Pain Syndrome Key Companies

  • Abiogenic Pharma
  • Soin Therapeutics and many others

 Complex Regional Pain Syndrome Therapies 

  •  Neridronate
  • Non-narcotic Strong Analgesic (TRPV1 Antagonist)(Grunenthel/Medifron
  • Physical Therapy and Occupational Therapy
  •  Low Dose Naltrexone and many others.

Table of Contents

1. Key Insights 

2. Report Introduction 

3 Executive Summary of Complex Regional Pain Syndrome 

4 Disease Background and Overview

5 Epidemiology and patient population

6 The United States 

7 EU 5

8 Complex Regional Pain Syndrome  Emerging Therapies

9. Complex Regional Pain Syndrome Market Outlook

10. Market Access and Reimbursement of Therapies

11. Appendix

12. Hemophilia Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

15. About DelveInsight

Click here to read more about  Complex Regional Pain Syndrome Market Landscape

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

  Categories: